Retatrutide is a newly discovered substance that shows promise as a treatment for type 2 diabetes. It functions as a agonist of the glucagon-like peptide-1 (GLP-1) receptor, which plays a crucial role in regulating https://fayhscg429151.ltfblog.com/37678526/dulaglutide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes